1.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: TS-102, NCT01483027
|
|
2.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: TS-103, NCT01556490
|
|
3.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: PCI-IRB-0611014, PCI-IRB-000656, PCI-IRB-000871, NCI-V02-1701, NCT00039078
|
|
4.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: NU 1365-002, P30CA060553, NCT00532740
|
|
5.
|
Phase: Phase II Type: Treatment Status: Active Age: Over 18 Sponsor: NCI, Other Protocol IDs: STU 12339, P30CA060553, STU# 00012339, CDR0000651416, NU-09I2, IRB# STU00012339, NCT00956930
|
|
6.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: J09150, NA_00035790, J09150, NCT01177007
|
|
7.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: MCC-16236, NCT01253148
|
|
8.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: UCSF-SIRT-HCC, NCT01290523
|
|
9.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and ove Sponsor: Other Protocol IDs: 2011/050, NCT01381211
|
|
10.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: TS001RSUM, NCT01473004
|
|
11.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: MCC-16764, NCT01581307
|
|
12.
|
Phase: Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: NU 08I5, STU00007062, NCT00858429
|
|
13.
|
Phase: Phase I Type: Diagnostic, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: WCI1907-10, NCT01434459
|
|
14.
|
Phase: No phase specified Type: Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: NU 1365-001, P30CA060553, NCT00530010
|
|
15.
|
Phase: No phase specified Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: TheraSphere - 421.03, NCT00683631
|
|
16.
|
Phase: No phase specified Type: Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: STX0206, NCT00724503
|
|
17.
|
Phase: No phase specified Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 08-029 TheraSphere®, NCT00877136
|
|
18.
|
Phase: No phase specified Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 2002-2242, CA-60396,, PHS-NIH Natl Cancer Inst, NCT00906984
|
|
19.
|
Phase: No phase specified Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 2008-0770, NCT01176604
|
|
20.
|
Phase: No phase specified Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 07D.366, 2007-49, NCT01349075
|
|
21.
|
Phase: No phase specified Type: Treatment Status: Active Age: Over 18 Sponsor: Other Protocol IDs: XHEP0016-NOT-RESEARCH, HEP0016, NCT01076517
|
|
22.
|
Phase: No phase specified Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 00015167, NCT01556282
|